RT Book, Section
A1 Kayani, Waleed
A1 Deswal, Anita
A2 Baliga, R. R.
A2 Abraham, William T.
SR Print(0)
ID 1161018254
T1 Neurohormonal Blockade in Heart Failure
T2 Color Atlas and Synopsis of Heart Failure
YR 2018
FD 2018
PB McGraw-Hill Education
PP New York, NY
SN 9780071749381
LK accesscardiology.mhmedical.com/content.aspx?aid=1161018254
RD 2024/04/23
AB A  55-year-old  man  with  hypertension,  diabetes  mellitus  and  recent  drug  eluting  stent  placement  to  left  anterior  descending  (LAD)  artery  after  suffering  a  myocardial  infarction  comes  to  your  clinic  after  being  discharged  from  the  hospital.  He  is  able  to  carry  out  daily  activities  with  ease  but  reports  getting  short  of  breath  on  climbing  2  sets  of  stairs.  An  echocardiogram  done  during  the  hospitalization  revealed  an  left  ventricular  ejection  fraction  (LVEF)  of  35%-39%  with  wall  motion  abnormalities  in  LAD  territory.  He  mentions  compliance  with  his  regimen  of  Aspirin  81  mg  once  daily,  Clopidogrel  75  mg  once  daily,  Amlodipine  5  mg,  Atorvastatin  80  mg  and  Furosemide  20  mg  once  daily.  On  examination  his  blood  pressure  is  147/87  and  heart  rate  76  beats  per  minute,  he  appears  in  no  acute  distress,  JVP  is  7  cm  H2O,  lungs  are  clear,  heart  sounds  are  regular  with  no  murmurs  and  no  lower  extremity  edema  is  noted.  He  asks  about  additional  therapies  to  help  recover  improve  his  heart  function  and  quality  of  life.